P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.

• Michael Dickinson,
• Leanne Berkahn,
• Judith Trotman,
• Jason Butler,
• Paul Neeson,
• Matthias Bressel,
• Adrian Minson

Affiliations

Michael Dickinson

1 Peter MacCallum Cancer Centre, Melbourne, Australia

Leanne Berkahn

4 Auckland City Hospital, Auckland, New Zealand

Judith Trotman

6 Concord Repatriation General Hospital, Concord, Australia

Jason Butler

8 Royal Brisbane and Women’s Hospital, Herston, Australia

Paul Neeson

3 University of Melbourne, Sir Peter MacCallum Department of Oncology, Parkville, Australia

Matthias Bressel

3 University of Melbourne, Sir Peter MacCallum Department of Oncology, Parkville, Australia

Adrian Minson

1 Peter MacCallum Cancer Centre, Melbourne, Australia